candesartan cilexetil and hydrochlorothiazide

Generic: candesartan cilexetil and hydrochlorothiazide

Labeler: mylan pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name candesartan cilexetil and hydrochlorothiazide
Generic Name candesartan cilexetil and hydrochlorothiazide
Labeler mylan pharmaceuticals inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

candesartan cilexetil 16 mg/1, hydrochlorothiazide 12.5 mg/1

Manufacturer
Mylan Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 0378-3001
Product ID 0378-3001_b308024b-d9c2-4b12-ac28-cb2e295ab1bf
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090704
Marketing Start 2012-12-04
Marketing End 2027-02-28

Pharmacologic Class

Established (EPC)
thiazide diuretic [epc]
Chemical Structure
thiazides [cs]
Physiologic Effect
increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 03783001
Hyphenated Format 0378-3001

Supplemental Identifiers

RxCUI
578325 578330 802749
UPC
0303783003771 0303783001777 0303783002774
UNII
0J48LPH2TH R85M2X0D68
NUI
N0000175359 N0000175419 M0471776

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name candesartan cilexetil and hydrochlorothiazide (source: ndc)
Generic Name candesartan cilexetil and hydrochlorothiazide (source: ndc)
Application Number ANDA090704 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 16 mg/1
  • 12.5 mg/1
source: ndc
Packaging
  • 90 TABLET in 1 BOTTLE, PLASTIC (0378-3001-77)
source: ndc

Packages (1)

Ingredients (2)

candesartan cilexetil (16 mg/1) hydrochlorothiazide (12.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b308024b-d9c2-4b12-ac28-cb2e295ab1bf", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0303783003771", "0303783001777", "0303783002774"], "unii": ["0J48LPH2TH", "R85M2X0D68"], "rxcui": ["578325", "578330", "802749"], "spl_set_id": ["f3c4f7ed-e667-4528-a675-b032c2a4425d"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (0378-3001-77)", "package_ndc": "0378-3001-77", "marketing_end_date": "20270228", "marketing_start_date": "20121204"}], "brand_name": "Candesartan Cilexetil and Hydrochlorothiazide", "product_id": "0378-3001_b308024b-d9c2-4b12-ac28-cb2e295ab1bf", "dosage_form": "TABLET", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "0378-3001", "generic_name": "candesartan cilexetil and hydrochlorothiazide", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Candesartan Cilexetil and Hydrochlorothiazide", "active_ingredients": [{"name": "CANDESARTAN CILEXETIL", "strength": "16 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}], "application_number": "ANDA090704", "marketing_category": "ANDA", "marketing_end_date": "20270228", "marketing_start_date": "20121204"}